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Sensitivity to Meropenem
Conclusion: The use of Levolfoxacin as a prophylactic agent
had not resulted in a statistically signiﬁcant increase of resistance
among the common Gram negative pathogens. However, close
monitoring is warranted as a trend towards increase in the pro-
portion of resistance was noted.
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Background: Despite the availability of potent new anti-
microbial agents and vaccines, Community Acquired Pneumonia
(CAP) remains a common and serious illness .The microbial etiolo-
gies and their resistant patterns vary widely. Frequent, irrational
and unnecessary use of antibiotics, changes in environment,
changes in lifestyle and increased mobility of the people have con-
tributed to changes in the patterns of microbial proﬁles and their
resistant patterns in the Community. Unfortunately, there have
been very few studies done regarding etiology of CAP, prevalence
of causative organisms and their resistance pattern in Nepal. Thus
it was quite crucial to detect them in our context
Methods & Materials: A descriptive cross-sectional study con-
ducted over a period of six months (March 2011–August 2011) at
Bacteriology laboratory of Tribhuvan University and Teaching Hos-
pial (TUTH) among 600 clinically diagnosed CAP patients visiting
TUTH-OPD. Sputum samples that met the acceptance criteria of
ASM were further processed according to the standard methodol-
ogy.
Results: Bacterial etiologies could be identiﬁed only in 25.5% of
cases of CAP. Haemophilus inﬂuenzae (26.9%), Streptococcus pneu-
moniae (20.0%) and Pseudomonas aeruginosa (19.4%) were the
commonest bacterial etiologies, Twenty-six percent ofH. inﬂuenzae
isolates were MDR The prevalence of MDR bacteria in CAP patients
was 41.25%. Among gram-negative bacterial isolates, the highest
number of MDR was seen in Pseudomonas aeruginosa, followed by
Klebsiella pneumoniae, E. coli and Acinetobacter spp.
The prevalence of ESBL, AmpC and MBL producing gram-
negative bacteria were 10.1% (more common among Klebsiella
pneumoniae (16.6%), 5.8% and 4.3% (more common among Acine-
tobacter spp(14.29%) respectively.
Conclusion: Different bacteria are responsible for CAP in our
setting. MDR, ESBL, MBL and AmpC producing bacterial strains are
present in our Community also. Thus it has demanded to take spe-
cial care during treatment of patients with community acquired
infections also and also sought for other similar type of exten-
sive studies on large number of community isolates to characterize
their genetic relatedness and resistant patterns so that appropriate
measures can be applied.
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Background: Staphylococcus aureus (S. aureus) is an important
pathogen for hospital-associated infections, and it is especially dif-
ﬁcult to treat because of emerging resistance tomany antimicrobial
drugs. Methicillin-resistant S. aureus (MRSA) have emerged as a
clinically relevant human pathogen. Intracellular destruction of
invading S. aureus is mainly mediated by phagocytosis, and this
phagocytic process is crucial to the host innate defense against
Staphylococci, so, disorders of phagocytic cells- as in cases of
leukemia- cause frequency of infections at epithelial surfaces and
the frequency of dissemination. The aim of study is to evaluate
MRSA strains isolated from leukemia patients admitted to hospitals
in regard to drug resistance.
Methods&Materials: A cross-sectional studywas conducted at
the Hematology center/Al-Mustansiriya University- Baghdad, from
November 2013 toMarch2014,where 48 known leukemia patients
aged from 15 to 81 years have been enrolled for the detection of
MRSA in their blood. Blood culture and conventionalmethodswere
used for the isolation and identiﬁcation of pathogenic bacteria,
along with the phenotypic and genotypic methods (i.e. detection
of “PBP2a”) for the identiﬁcation of MRSA. Antibiotic susceptibility
testing and vancomycin minimum inhibitory concentration (MIC)
were also performed for all S. aureus isolates.
Results: Positive blood culture resultswere detected in 34 (71%)
of patients. Among them, S. aureus was accounted for 11 (26.8%) of
isolates. Antibiotics susceptibility tests for S. aureus isolates showed
that 9 (82%) strains isolated from patients in current study were
of MRSA variety. All of the S. aureus strains (100%) in current
study were susceptible to Carbapenems. Intermediate resistance
to vancomycin was noticed in 4 (36.4%) S. aureus isolates (i.e.
